HALO Financial Facts
Cost of product sales: 9.13MResearch and development: 33.86M
See Full Income Statement
See Full Balance Sheet
Halozyme (HALO) Earnings
|
Expand Research on HALO
| Next EPS Date | 11/9/26 | EPS Growth Rate | +30.2% |
|---|---|---|---|
| Average EPS % Beat Rate | -19.0% | Revenue Growth Rate | +36.2% |
| Average % Move 1-Wk after EPS | -2.1% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
11/9/26  |
Q326 | N/A | $2.24 | N/A | N/A | $482.27M |  |
N/A | N/A | ||
| 8/6/26 |
Q226 | $2.28 | $1.81 | +$0.47 | $481M | $401.27M | |
 | | Details | |
| 5/11/26 | Q126 | $1.60 | $1.54 | +$0.06 | $377M | $358.45M | |
| | Details | |
| 2/17/26 | Q425 | -$0.24 | $1.90 | -$2.14 | $451.76M | $393.92M | |
| | Details | |
| 11/3/25 | Q325 | $1.72 | $1.61 | +$0.11 | $354M | $340.12M | = | | | Details | |
| 8/5/25 | Q225 | $1.54 | $1.24 | +$0.30 | $326M | $286.01M | = | | | Details | |
| 5/6/25 | Q125 | $1.11 | $0.98 | +$0.13 | $265M | $229.29M | = | | | Details | |
| 2/18/25 | Q424 | $1.26 | $1.15 | +$0.11 | $298M | $294.15M | = | | | Details |
